Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (111-120 of 290) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|June 15, 2018
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodiesClément Vialatte de Pémille, Giulia Berzero, Mathilde Small, et al.
The Oncologist|July 13, 2016
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated GliomasMarianne Labussière, Amithys Rahimian, Marine Giry, et al.
Neuro-Oncology|December 12, 2013
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade gliomaEmeline Tabouret, Françoise Boudouresque, Maryline Barrie, et al.
Neuro-Oncology Advances|February 4, 2022
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastomaBaptiste Sourty, Laure-Marie Dardaud, Céline Bris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasMarc Sanson, Yannick Marie, Sophie Paris, et al.
Journal of Neuro-Oncology|March 4, 2009
No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosisBlandine Boisselier, Yannick Marie, Soufiane El Hallani, et al.
Neurology|August 24, 2014
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarianne Labussière, Blandine Boisselier, Karima Mokhtari, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 22, 2021
PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growthNathalie Magne, Véronique Rousseau, Kévin Duarte, et al.
Annals of Neurology|September 1, 2005
Two types of chromosome 1p losses with opposite significance in gliomasAhmed Idbaih, Yannick Marie, Gaëlle Pierron, et al.
Neuro-Oncology|April 12, 2012
Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteriaJaime Gállego Pérez-Larraya, Marion Lahutte, Gregorio Petrirena, et al.
Pageof 29

Showing results (111-120 of 290) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|June 15, 2018
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodiesClément Vialatte de Pémille, Giulia Berzero, Mathilde Small, et al.
The Oncologist|July 13, 2016
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated GliomasMarianne Labussière, Amithys Rahimian, Marine Giry, et al.
Neuro-Oncology|December 12, 2013
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade gliomaEmeline Tabouret, Françoise Boudouresque, Maryline Barrie, et al.
Neuro-Oncology Advances|February 4, 2022
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastomaBaptiste Sourty, Laure-Marie Dardaud, Céline Bris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasMarc Sanson, Yannick Marie, Sophie Paris, et al.
Journal of Neuro-Oncology|March 4, 2009
No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosisBlandine Boisselier, Yannick Marie, Soufiane El Hallani, et al.
Neurology|August 24, 2014
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarianne Labussière, Blandine Boisselier, Karima Mokhtari, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 22, 2021
PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growthNathalie Magne, Véronique Rousseau, Kévin Duarte, et al.
Annals of Neurology|September 1, 2005
Two types of chromosome 1p losses with opposite significance in gliomasAhmed Idbaih, Yannick Marie, Gaëlle Pierron, et al.
Neuro-Oncology|April 12, 2012
Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteriaJaime Gállego Pérez-Larraya, Marion Lahutte, Gregorio Petrirena, et al.
Pageof 29